27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Johnson & Johnson (NYSE:JNJ) announced preliminary results from an independent study, including a subset of the Janssen-sponsored COV2008 study participants. The article describing these results has been posted on medRxiv.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- The study showed a booster shot of the Johnson & Johnson COVID-19 vaccine, administered six months after a two-dose primary regimen of Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ:BNRX) BNT162b2 (Comirnaty) increased antibody and T-cell responses.
- These results demonstrate the potential benefits of heterologous boosting (mix-and-match).
- These Phase 2 data are reinforced by preliminary results from the UK COV-BOOST clinical study published in The Lancet.
- The study demonstrated that following primary vaccination with two doses of either BNT162b2 or AstraZeneca Plc's (NASDAQ: AZN) (Covishield) ChAdOx1 nCov-19, a booster dose of the Johnson & Johnson COVID-19 vaccine increased both antibody and T-cell responses.
- The Johnson & Johnson COVID-19 vaccine and BNT162b2 as boosters led to similar neutralizing and binding antibody levels four weeks following the boost.
- However, after a mix-and-match booster dose of the Johnson & Johnson COVID-19 vaccine, antibodies continued to increase for at least four weeks.
- In contrast, antibodies declined from week two to week four post-boost in individuals who received a homologous boost with the BNT162b2 vaccine.
- Also Read: Valneva's COVID-19 Shot Fails As Booster In Pfizer/BioNTech Vaccinated Population.
- Price Action: JNJ shares are up 0.68% at $160.47 during the premarket session on the last check Monday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.